生物活性 | |||
---|---|---|---|
靶点 |
|
||
描述 | Mianserin Hydrochloride is an potent antagonist of H1 histamine receptor and 5-HT serotonin receptors, used for the treatment of depression. Mianserin (2 mg/kg s.c.) causes a modest increase of DOPAC (Dihydroxyphenylacetic acid) levels up to about 30% above base-line, which is statistically significant when compared to saline. Mianserin increases extracellular norepinephnne, but a comparison with desipramine and idazoxan showed that both NE reuptake inhibition and alpha-2 autoreceptor blockade contributed to the mianserin-induced increase in extracellular norepinephnne[3]. Mianserin (1, 5 and 10 mg/kg, SC) dose-dependently increases up to about 6 times extracellular dopamine in the medial prefrontal cortex of the rat. Mianserin also dose-dependently increases extracellular noradrenaline in the prefrontal cortex. Mianserin also dose-dependently increased extracellular noradrenaline in the prefrontal cortex[4]. Rats were chronically treated with mianserin (10 mg/kg i.p.) or eltoprazine (1 mg/kg i.p.) and were tested in the elevated plus-maze test for anxiety. Mianserin and eltoprazine displayed opposite effects in the elevated plus-maze: mianserin induced anxiolytic-like effects, while eltoprazine showed anxiogenic-like ones[5]. |
临床研究 | |||||
---|---|---|---|---|---|
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT00926835 | Major Depressive Disorder | Phase 4 | Terminated(due to patient recr... 展开 >>uitment difficulties) 收起 << | - | Korea, Republic of ... 展开 >> Clinical research center for depression Seoul, Korea, Republic of, 150713 收起 << |
NCT02336750 | Breast Cancer | Phase 3 | Recruiting | December 2019 | China ... 展开 >> Fudan University Cancer Hospital Recruiting Shanghai, China, 200032 Contact: Xichun Hu, MD,PhD 64175590 ext 5006 huxicun@gmail.com Contact: Jun Cao, MD 64175590 ext 5009 caojun1115lemon@163.com 收起 << |
NCT01764867 | Major Depressive Disorder | Phase 4 | Unknown | December 2014 | China ... 展开 >> Shanghai Mental Health Center Recruiting Shanghai, China, 200030 Contact: Zhiguo Wu, M.D. 862134289888 ext 3528 wu_zhiguo@yahoo.com.cn Principal Investigator: Yiru Fang, Ph.D., M.D. 收起 << |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
3.32mL 0.66mL 0.33mL |
16.62mL 3.32mL 1.66mL |
33.24mL 6.65mL 3.32mL |
参考文献 |
---|